Colorectal cancer remains a major digestive health concern in New York, with thousands of residents diagnosed each year and about 1,000 deaths occurring annually in New York City alone. The statistics also show a clear relationship between age, screening, diagnosis rates, racial disparities, and colorectal cancer outcomes.
Colorectal cancer develops in the colon or rectum, which form the lower part of the digestive system. New York State maintains a cancer registry that tracks incidence, mortality, stage at diagnosis, survival, and geographic differences, providing a detailed picture of the disease across the state. For people seeking specialized digestive care in New York, a Dr. Gina Sims Gastroenterologist provides clinical evaluation when symptoms or screening results require professional attention.
The numbers also show why prevention and screening remain central to digestive health. New York City reported a 63.3% colorectal cancer screening rate among adults ages 45 to 75 in 2021, meaning more than 1 in 3 people in that age group were not up to date with screening at that time.
How common is colorectal cancer in New York?
Colorectal cancer is one of the most frequently diagnosed cancers in New York State, with almost 8,800 new cases reported among men and women each year according to the state’s cancer information. The disease includes cancers originating in the colon and rectum and represents a major part of the state’s gastrointestinal cancer burden.
New York State reports that almost 4,600 men and more than 4,200 women are diagnosed with colorectal cancer annually. The state also reports almost 1,500 male deaths and more than 1,400 female deaths from colorectal cancer each year.
These figures show why colorectal cancer statistics matter to digestive health planning. The New York State Cancer Registry tracks incidence and mortality by age, sex, race and ethnicity, county, year, and cancer site, allowing public health officials to identify differences across populations and locations.
What do New York City colorectal cancer statistics show?
New York City records about 3,500 colorectal cancer diagnoses and approximately 1,000 colorectal cancer deaths each year. Colorectal cancer remains one of the leading causes of cancer death in the city, making screening and early detection important components of digestive healthcare.
New York City has also recorded substantial improvement over time. From 2000 through 2018, the city’s colorectal cancer incidence rate declined from 57.7 to 35.5 cases per 100,000 people, representing an average annual decline of 2.7%. Mortality declined from 19.0 to 10.4 deaths per 100,000 people between 2001 and 2018, an average annual decline of 3.3%.
The decline reflects the effect of screening, improvements in treatment, and changes in risk factors. The long term trend demonstrates that colorectal cancer outcomes respond to prevention and early detection efforts rather than remaining fixed over time.
How does age affect colorectal cancer statistics in New York?
Age is one of the strongest factors associated with colorectal cancer because approximately 60% of newly diagnosed New York State patients are age 65 or older. Nearly 90% of colorectal cancers in the state are diagnosed at age 50 or older according to New York State health data.
Age also explains why colorectal cancer screening becomes increasingly important during adulthood. The disease develops through changes in cells lining the colon or rectum, and the accumulation of cellular changes over time contributes to increasing risk with age.
The age pattern does not mean younger adults are protected from colorectal cancer. National data show increasing incidence among younger adults, making awareness of symptoms and appropriate screening important even before traditional older age groups.
Why are colorectal cancer rates increasing among some younger adults?
Colorectal cancer incidence has increased among younger adults in the United States even while overall incidence has declined. From 2012 through 2021, colorectal cancer incidence increased by 2.4% per year among adults younger than 50 and by 0.4% per year among adults ages 50 to 64.
At the same time, incidence declined by about 1% per year across the overall U.S. population during that period. The decline was concentrated among adults age 65 and older, showing that the national trend differs substantially by age group.
These statistics support attention to symptoms across adulthood. Rectal bleeding, persistent changes in bowel habits, unexplained weight loss, persistent abdominal discomfort, and iron deficiency anemia require appropriate medical evaluation rather than being attributed automatically to age or minor digestive problems.
How has colorectal cancer screening changed digestive health outcomes in New York?
Colorectal cancer screening has contributed to lower colorectal cancer incidence and mortality in New York City by identifying cancer and precancerous growths before they progress. Screening includes tests that detect blood or abnormal genetic material in stool and examinations such as colonoscopy that directly inspect the colon.
Colonoscopy also provides an important preventive function because physicians remove many precancerous polyps during the same examination. Removing these growths interrupts the progression from abnormal tissue to invasive colorectal cancer.
New York City reported that 63.3% of adults ages 45 to 75 were up to date with colorectal cancer screening in 2021. The rate was 70.8% among Black non-Latino adults, 66.6% among White adults, 62.2% among Latino adults, and 48.1% among Asian or Pacific Islander adults in that survey.
What do New York screening rates tell us about prevention?
New York screening statistics show that a substantial portion of eligible adults remain overdue for colorectal cancer screening. New York City reported that more than 30% of residents over age 45 were not up to date with screening according to recent city health information.
Screening status matters because colorectal cancer develops through a process that frequently begins with precancerous polyps. Detecting and removing these lesions prevents some cancers from developing and also identifies existing cancers at earlier stages.
Screening recommendations depend on age, personal medical history, family history, previous colonoscopy findings, and other risk factors. Adults should discuss the appropriate screening method and interval with their healthcare professional.
What do racial differences in New York colorectal cancer statistics show?
New York City colorectal cancer statistics show persistent racial differences in both incidence and mortality, with Black non-Latino New Yorkers experiencing higher rates than several other racial and ethnic groups. These differences represent an important public health issue involving screening, diagnosis, treatment, healthcare access, and broader social factors.
From 2014 through 2018, colorectal cancer incidence in New York City was 40.5 cases per 100,000 among Black non-Latino residents, compared with 38.9 among White residents, 32.8 among Latino residents, and 35.0 among Asian residents. Mortality during the same period was 14.8 deaths per 100,000 among Black non-Latino residents compared with 11.8 among White residents, 9.8 among Latino residents, and 8.5 among Asian residents.
These differences demonstrate why population level statistics need to be considered alongside individual risk factors. Screening access, timely diagnosis, treatment quality, family history, and underlying health conditions all contribute to colorectal cancer outcomes.
How does New York compare with national colorectal cancer statistics?
New York’s colorectal cancer burden fits within a larger national pattern in which colorectal cancer remains a major cause of cancer illness and death. The National Cancer Institute estimated 154,270 new colorectal cancer cases and 52,900 deaths in the United States for 2025.
The national statistics also show a major age difference. From 2012 through 2021, colorectal cancer incidence declined among adults age 65 and older while increasing among younger adults, demonstrating that the national decline is not shared equally across age groups.
New York’s state and city registries provide more localized information than national estimates. The New York State Cancer Registry publishes statistics by county, New York City neighborhood, age, sex, race and ethnicity, cancer site, diagnosis year, mortality, and survival.
What does the colorectal cancer mortality rate tell us?
The colorectal cancer mortality rate measures deaths attributed to the disease within a defined population and time period. Mortality statistics show the burden of fatal disease, while incidence statistics show how frequently new cases are diagnosed.
These measurements answer different questions. A high incidence rate indicates more newly diagnosed disease, while a high mortality rate indicates a greater number of deaths relative to the population size.
New York City reduced colorectal cancer mortality from 19.0 to 10.4 deaths per 100,000 people between 2001 and 2018. This 45% reduction demonstrates substantial long term improvement in colorectal cancer outcomes in the city.
What does the stage of colorectal cancer diagnosis tell us?
Cancer stage describes how far colorectal cancer has progressed when it is diagnosed, making stage one of the most important factors in understanding prognosis and treatment. Localized colorectal cancer remains confined to the bowel, while advanced disease involves spread to regional lymph nodes or distant organs.
The New York State Cancer Registry tracks stage at diagnosis alongside incidence and mortality. This information helps identify whether populations are receiving diagnoses at earlier or later stages.
Early detection changes treatment options and outcomes because localized colorectal cancer is more treatable than disease that has spread to distant organs. Screening therefore addresses both disease prevention through polyp removal and early detection through identification of existing cancer.
What do colorectal cancer statistics say about digestive health in older adults?
Colorectal cancer statistics show that older adults carry a substantial share of the disease burden, with approximately 60% of new New York State colorectal cancer diagnoses occurring among people age 65 and older. Age therefore remains an important factor in colorectal cancer prevention and screening.
The New York State 2023 mortality data also show that deaths from colon and rectal cancers occur predominantly in older age groups. Among recorded colon cancer deaths, substantial numbers occurred in people ages 65 to 74 and 75 or older.
Age alone does not determine an individual’s risk. Family history, previous polyps, inflammatory bowel disease, smoking, alcohol use, obesity, physical inactivity, and dietary factors also influence colorectal cancer risk.
How important is family history in colorectal cancer risk?
Family history is an established colorectal cancer risk factor because inherited genetic changes and shared family exposures affect an individual’s likelihood of developing the disease. A parent, sibling, or child with colorectal cancer provides clinically relevant information for determining screening needs.
Risk also increases with a personal history of colorectal polyps or colorectal cancer. Certain inherited syndromes, including Lynch syndrome and familial adenomatous polyposis, produce substantially elevated colorectal cancer risk.
People with a strong family history require individualized screening guidance. Their screening schedule can differ from the schedule used for adults at average risk.
Which colorectal cancer symptoms should New Yorkers take seriously?
Persistent rectal bleeding, blood in stool, unexplained weight loss, persistent abdominal pain, iron deficiency anemia, and a sustained change in bowel habits require medical evaluation. Colorectal cancer frequently develops without symptoms during its early stages, which makes screening important even when a person feels healthy.
Changes in bowel habits include persistent diarrhea, constipation, narrower stools, or a repeated change from a person’s normal pattern. These symptoms also have noncancerous causes, so clinical evaluation is required to determine the underlying cause.
Rectal bleeding should not automatically be attributed to hemorrhoids. A healthcare professional evaluates bleeding according to the person’s age, symptoms, medical history, screening status, and risk factors.
What do the numbers say about the value of early detection?
The statistics show that earlier detection and prevention are central to reducing colorectal cancer deaths. Screening identifies precancerous polyps and cancers before symptoms develop, while treatment outcomes are strongest when disease remains localized.
New York City’s long term decline in colorectal cancer incidence and mortality occurred alongside increased use of screening and other improvements in cancer prevention and treatment. The city’s incidence rate fell from 57.7 to 35.5 per 100,000 between 2000 and 2018, while mortality fell from 19.0 to 10.4 per 100,000 between 2001 and 2018.
These numbers provide a population level measure of progress. They also show why maintaining screening participation remains important as the population changes and colorectal cancer patterns among younger adults evolve.
How should New Yorkers use colorectal cancer statistics for personal health decisions?
New Yorkers should use colorectal cancer statistics as population level evidence while making personal screening decisions based on age, family history, medical history, symptoms, and individual risk factors. A population rate does not determine whether a particular person has colorectal cancer.
The New York State Cancer Registry provides data by county, neighborhood, age, sex, race and ethnicity, stage, and year. These datasets help identify public health patterns but do not replace an individual’s clinical assessment.
Adults should keep track of their screening history and discuss the appropriate testing interval with a healthcare professional. People with symptoms or elevated risk require individualized evaluation rather than relying on population averages.
What are the most important questions about colorectal cancer statistics in New York?
How many people in New York State develop colorectal cancer each year?
New York State reports almost 8,800 colorectal cancer diagnoses annually, including almost 4,600 men and more than 4,200 women. The disease remains one of the state’s most frequently diagnosed cancers.
Source: New York State Department of Health.
How many people in New York City die from colorectal cancer each year?
New York City reports about 1,000 colorectal cancer deaths each year. Colorectal cancer remains one of the city’s leading causes of cancer death.
Source: New York City Department of Health and Mental Hygiene.
At what age does colorectal cancer become more common?
Colorectal cancer becomes substantially more common with increasing age, with approximately 60% of new New York State cases diagnosed in people age 65 or older. Nearly 90% of cases occur at age 50 or older according to state data.
Source: New York State Department of Health.
Why is colorectal cancer screening important for people without symptoms?
Colorectal cancer screening detects precancerous polyps and cancers before symptoms develop. Colonoscopy also allows physicians to remove many precancerous polyps during the examination.
Source: National Cancer Institute.
Are younger adults developing colorectal cancer more frequently?
Yes, colorectal cancer incidence increased among U.S. adults younger than 50 by 2.4% per year from 2012 through 2021. During the same period, incidence declined among adults age 65 and older.
Source: National Cancer Institute.
Which New York population has experienced higher colorectal cancer rates?
Black non-Latino New Yorkers have experienced higher colorectal cancer incidence and mortality rates than several other racial and ethnic groups. New York City data show persistent disparities in both disease burden and outcomes.
Source: New York City Department of Health and Mental Hygiene.
Does a normal bowel pattern rule out colorectal cancer?
No, a normal bowel pattern does not rule out colorectal cancer because early colorectal cancer frequently produces no symptoms. Age appropriate screening remains important for eligible adults regardless of the absence of digestive symptoms.
Source: National Cancer Institute.
What should someone do after noticing blood in their stool?
A person who notices unexplained blood in the stool should seek medical evaluation rather than assuming the bleeding comes from hemorrhoids. The appropriate assessment depends on age, symptoms, screening history, medical history, and other risk factors.
Source: National Cancer Institute.